抑郁症的药物治疗进展

范志雄; 谢和辉

doi:10.3969/j.issn.1006-0111.2012.03.002

抑郁症的药物治疗进展

doi: 10.3969/j.issn.1006-0111.2012.03.002

范志雄¹,
谢和辉^2,

1.
第二军医大学研究生管理大队临床十队,上海 200433
2.
第二军医大学药学院药理学教研室,上海 200433

Progress on drug treatment of depression

FAN Zhi-xiong¹,
XIE He-hui^2
,

1.
No.10 team of Clinical , Graduate Administration Division, Second Military Medical University, Shanghai 200433,China
2.
Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433,China

摘要: 抑郁症是一种常见的精神疾病,其发病率在不断上升,而且难以治愈。目前抑郁症的治疗药物主要包括:三环类抗抑郁药、单胺氧化酶抑制剂和可逆性选择性单胺氧化酶抑制药、选择性5-HT再摄取抑制剂、选择性NE再摄取抑制剂、5-HT及NA再摄取抑制药、NA及DA再摄取抑制药等。本文就抗抑郁药及特殊情况下抑郁症的药物治疗进展作一综述。
- 抑郁症 /
- 抗抑郁药 /
- 脑卒中 /
- 心力衰竭 /
- 妊娠期抑郁
Abstract: Depression was a common mental disorder. Nowdays, anti-depressants included tricyclic antidepressants, monoamine oxidase inhibitors and reversible selective monoamine oxidase inhibitors, selective serotonin reuptake inhibitors, selective noradrenergic reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, norepinephrine and dopamine reuptake inhibitors. The progress on drug treatment of depression were reviewed in this paper.
- depression /
- anti-depressants /
- stroke /
- heart failure /
- depression during pregnancy

[1]	Kessler RC,Berglund P,Demler O.The epidemiology of major depressive disorder:results from the national comorbidity survey replication(NCS-R)[J].JAMA, 2003, 89(2): 3095.
[2]	Kriston L, von Wolff A, Hlzel L. Effectiveness of psychotherapeutic, pharmacological,and combined treatments for chronic depression: a systematic review[J]. BMC Psychiatry, 2010, 10: 95.
[3]	Youdim MB, Weinstock M. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation[J]. Neurotoxicology, 2004, 25(1-2): 243.
[4]	郭鹏, 丁素菊. 抗抑郁药物临床应用进展[J]. 药学服务与研究, 2009, 9(6): 405.
[5]	Tandt H, Audenaert K. SSRIs(selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children[J]. Tijdschr Psychiatr, 2009, 51(6): 387.
[6]	Baldwin D, Woods R. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis[J]. BMJ, 2011, 11: 342.
[7]	Mullins CD,Shaya FT.Comparison of first refill rates among users of sertrallne paroxetine, and citalopram[J]. Clin Ther, 2006, 28(2): 297.
[8]	Pogosova GV,Zhidko NI.Clinical effectiveness and safety of citalopram in patients with depression after myocardial infarction[J]. Kardiologiia, 2003, 43(1): 24.
[9]	Westenberq HG,Sandner C. Tolerability and safety of fluvoxamine and other antidepressants[J]. Int J Clin Pract, 2006, 60(4): 482.
[10]	Lundbeck H, Takeda P. Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety[J]. Drugs, 2010, 13(12): 900.
[11]	Eyding D, Lelgemann M, Grouven U, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials[J]. BMJ, 2010, 341: C4737.
[12]	Haine SE,Miljoen HP. Mianserin and ventricular tachycardia: case report and review of the literature[J]. Cardiology, 2006, 106(4): 195.
[13]	朱宇欢.新型抗抑郁药的临床应用[J].中国医院用药评价与分析, 2010, 10(7): 669.
[14]	Aurora RN,Zak RS. Best practice guide for the treatment of nightmare disorder in adults[J]. J Clin Sleep Med, 2010, 6(4): 389.
[15]	Racagni G, Popoli M. The pharmacological properties of antidepressants[J]. Int Clin Psychopharmacol, 2010, 25(3):117.
[16]	Nakayama K. Mechanism of action of new generation antidepressants under development in Japan: focusing on dopamine neurotransmission[J]. Nihon Shinkei Seishin Yakurigaku Zasshi, 2009, 29(3): 99.
[17]	陈瑞玲,赵志刚.抗抑郁症类药物的临床应用研究进展[J].中国临床药理学杂志,2007, 23(1): 54.
[18]	Girdler SS, Klatzkin R. Neurosteroids in the context of stress: Implications for depressive disorders[J]. Pharmacol Ther, 2007, 116: 125.
[19]	Gavioli EC, Calo'G. Antidepressant-and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands[J]. Naunyn Schmiedebergs Arch Pharmacol, 2006, 372: 319.
[20]	Catena-Dell'Osso M, Bellantuono C. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development[J]. Curr Med Chem, 2011, 18(2): 245.
[21]	Joffe RT. Hormone treatment of depression[J]. Dialogues Clin Neurosci, 2011, 13(1): 127.
[22]	Freeman MP,Rapaport MH. Omega-3 fatty acids and depression: from cellular mechanisms to clinical care[J]. J Clin Psychiatry.2011,72(2):258.
[23]	Zavoreo I, Basic-Kes V. Post-stroke depression[J]. Acta Clin Croat, 2009, 48(3): 329.
[24]	中国脑血管病防治指南编写委员会.中国脑血管病防治指南[M].北京:人民卫生出版社,2007,102.
[25]	Sondor H,Zsolt K.Clinical effectiveness and saftry of paroxetine in post-stroke depression[J]. Orv Hetil, 2006, 147(50): 2397.
[26]	Jassrsma T,Johansson P. Quality of life and symptoms of depression in advanced heart failure patients and their partners[J]. Curr Opin Support Palliat Care, 2010, 4(4): 233.
[27]	Marc L,Toureche N. Mind-body interventions during pregnancy for preventing or treating women's anxiety[J]. Cochrane Database Syst Rev, 2011, 7: CD007559.
[28]	Estrada-Camarena E,Lopez-Rubalcava C. Antidepressant effects of estrogens: a basic approximation[J]. Behav Pharmacol, 2010, 21(5-6): 451.

[1]	王鹏, 吴宗贵, 张争艳. 活心丸（浓缩丸）联合八段锦对急性心肌梗死合并心衰介入术后预后的影响 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202308034
[2]	史小飞, 陈弋, 陈枫, 景凯, 高越, 刘霞. 改善心力衰竭能量代谢的潜在药物研究进展 . 药学实践与服务, 2023, 41(5): 284-290. doi: 10.12206/j.issn.2097-2024.202205088
[3]	青胜利, 王淑娜, 汪东昇, 吕小群, 徐添颖, 缪朝玉. 肝脏特异性Nampt基因敲除对缺血性脑卒中的影响 . 药学实践与服务, 2022, 40(1): 12-19. doi: 10.12206/j.issn.1006-0111.202107068
[4]	张洁, 巢胜吾, 杨积顺. 中性粒细胞和淋巴细胞比值联合B型利钠肽对老年心力衰竭合并肺部感染的预测价值 . 药学实践与服务, 2022, 40(5): 469-472. doi: 10.12206/j.issn.2097-2024.202112010
[5]	王倩男, 黄心慧, 杨民绪, 杨星瑞, 朱可涵, 周婷婷. 肠道菌群相关的抗抑郁治疗研究进展 . 药学实践与服务, 2022, 40(5): 422-426. doi: 10.12206/j.issn.2097-2024.202111034
[6]	李夏珍, 宋薇薇, 何忠丽. 针灸结合选择性5-羟色胺再摄取抑制剂治疗抑郁症的临床疗效分析 . 药学实践与服务, 2021, 39(4): 366-368. doi: 10.12206/j.issn.1006-0111.202006099
[7]	刘世钰, 赵亮, 陈俊, 张国庆. 基于组学技术的抑郁症相关生物标志物研究进展 . 药学实践与服务, 2018, 36(3): 198-203. doi: 10.3969/j.issn.1006-0111.2018.03.002
[8]	姚媛, 周艺, 周婷婷. 抑郁症致病机制及中药治疗抑郁症的机制研究 . 药学实践与服务, 2018, 36(3): 193-197. doi: 10.3969/j.issn.1006-0111.2018.03.001
[9]	蔡建, 李明明, 张平, 费春华, 钱昌, 徐峰. 门诊抑郁患者的药物品牌偏好及对用药依从性和疗效的影响 . 药学实践与服务, 2017, 35(2): 154-157,164,181. doi: 10.3969/j.issn.1006-0111.2017.02.014
[10]	刘纯, 杨晓晨, 陈伯文, 尚尔宁. 重症脑卒中患者营养风险筛查与营养支持现状调查 . 药学实践与服务, 2016, 34(5): 408-411. doi: 10.3969/j.issn.1006-0111.2016.05.007
[11]	吴雅芳, 吴荣, 郭拥军. 左西孟旦静脉负荷与非负荷给药治疗难治性心力衰竭的临床观察 . 药学实践与服务, 2014, 32(4): 297-299,314. doi: 10.3969/j.issn.1006-0111.2014.04.016
[12]	成彦琼, 张浩, 王威, 顾小飞, 刘爱军. 叶酸在心脑血管疾病防治中的机遇与挑战 . 药学实践与服务, 2013, 31(5): 330-333,350. doi: 10.3969/j.issn.1006-0111.2013.05.003
[13]	韦龙静. 抑郁症治疗依从性研究概述 . 药学实践与服务, 2012, 30(6): 415-417,474. doi: 10.3969/j.issn.1006-0111.2012.06.005
[14]	方惠玉, 徐涛. 抑郁症的中西结合诊断治疗进展 . 药学实践与服务, 2011, 29(3): 181-183.
[15]	陈海飞, 卞俊, 宣伟东, 袁兵, 王朝武, 鲍蕾蕾, 周静静, 钱晓蓉. 郁可欣胶囊及其拆方对行为绝望抑郁症小鼠的影响 . 药学实践与服务, 2008, (4): 282-283,307.
[16]	瞿发林, 蔡灵芝, 蒋勤, 宋琰, 吴秋业. 钙增敏剂MCI-154治疗心衰分子作用机制的研究进展 . 药学实践与服务, 2008, (2): 84-86.
[17]	韩迎辰. 抑郁症及抗抑郁天然药物研究进展 . 药学实践与服务, 2005, (1): 3-5.
[18]	柯晓, 周宗梅, 文明, 文彩云. 黄芪注射液辅助治疗充血性心力衰竭的疗效及对免疫调节影响的观察 . 药学实践与服务, 2004, (5): 268-270.
[19]	丁洁卫, 唐志华, 阮调英. 文拉法辛、丙咪嗪、舍曲林治疗抑郁症的最小成本分析 . 药学实践与服务, 2002, (5): 303-304.
[20]	张紫洞. 三环类抗抑郁药过量的处理 . 药学实践与服务, 1988, (2): 13-14.

点击查看大图

计量

文章访问数: 3762
HTML全文浏览量: 253
PDF下载量: 976
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

抑郁症的药物治疗进展

doi: 10.3969/j.issn.1006-0111.2012.03.002

Progress on drug treatment of depression

计量

抑郁症的药物治疗进展

doi: 10.3969/j.issn.1006-0111.2012.03.002

1. 第二军医大学研究生管理大队临床十队,上海 200433

2. 第二军医大学药学院药理学教研室,上海 200433

English Abstract

Progress on drug treatment of depression

1. No.10 team of Clinical , Graduate Administration Division, Second Military Medical University, Shanghai 200433,China

2. Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433,China

全文HTML

目录

留言板

抑郁症的药物治疗进展

doi: 10.3969/j.issn.1006-0111.2012.03.002

Progress on drug treatment of depression

计量

出版历程

抑郁症的药物治疗进展

doi: 10.3969/j.issn.1006-0111.2012.03.002

1. 第二军医大学研究生管理大队临床十队,上海 200433 2. 第二军医大学药学院药理学教研室,上海 200433

English Abstract

Progress on drug treatment of depression

1. No.10 team of Clinical , Graduate Administration Division, Second Military Medical University, Shanghai 200433,China 2. Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433,China

全文HTML

目录

1. 第二军医大学研究生管理大队临床十队,上海 200433

2. 第二军医大学药学院药理学教研室,上海 200433

1. No.10 team of Clinical , Graduate Administration Division, Second Military Medical University, Shanghai 200433,China

2. Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433,China